Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Use a Fine Needle 5
The SURMOUNT-1 trial initially found that patients with obesity taking tirzepatide for 72 weeks lost 15% to 22.5% of their initial weight, on average, depending on the dose, and also saw a significant average reduction in their levels of glycated hemoglobin, known as A1c levels, a standard measure of blood sugar control
Rash has been reported by a small percentage of people using semaglutide injections and other GLP-1 medications during clinical trials and real-world use
Tirzepatide has received FDA approval and has established supply chains and pharmaceutical manufacturing standards
US$ 23.86
US$ 21.75
US$ 29.33
US$ 29.89
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 28.94
US$ 21.73
US$ 26.06
US$ 21.41
![SIMBA [8] BUTTERFLY SS](https://cdn.shopify.com/s/files/1/0852/5253/8682/files/SIMBA_8.webp?v=1703632730)
